Barclays’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-21,498
| Closed | -$39K | – | 4599 |
|
|
2023
Q1 | $39K | Sell |
21,498
-16,573
| -44% | -$30.1K | ﹤0.01% | 3846 |
|
|
2022
Q4 | $43K | Buy |
38,071
+9,528
| +33% | +$10.8K | ﹤0.01% | 3825 |
|
|
2022
Q3 | $66K | Sell |
28,543
-241,743
| -89% | -$559K | ﹤0.01% | 3571 |
|
|
2022
Q2 | $819K | Sell |
270,286
-189,623
| -41% | -$575K | ﹤0.01% | 2227 |
|
|
2022
Q1 | $3.12M | Sell |
459,909
-258,710
| -36% | -$1.76M | ﹤0.01% | 1452 |
|
|
2021
Q4 | $6M | Buy |
718,619
+678,473
| +1,690% | +$5.67M | ﹤0.01% | 1123 |
|
|
2021
Q3 | $298K | Sell |
40,146
-2,392
| -6% | -$17.8K | ﹤0.01% | 2809 |
|
|
2021
Q2 | $290K | Buy |
42,538
+19,196
| +82% | +$131K | ﹤0.01% | 2734 |
|
|
2021
Q1 | $239K | Buy |
23,342
+17,773
| +319% | +$182K | ﹤0.01% | 3056 |
|
|
2020
Q4 | $39K | Sell |
5,569
-2,833
| -34% | -$19.8K | ﹤0.01% | 3263 |
|
|
2020
Q3 | $68K | Sell |
8,402
-1,134
| -12% | -$9.18K | ﹤0.01% | 3168 |
|
|
2020
Q2 | $66K | Buy |
9,536
+3,945
| +71% | +$27.3K | ﹤0.01% | 3300 |
|
|
2020
Q1 | $26K | Sell |
5,591
-10,924
| -66% | -$50.8K | ﹤0.01% | 3324 |
|
|
2019
Q4 | $144K | Buy |
16,515
+5,578
| +51% | +$48.6K | ﹤0.01% | 3324 |
|
|
2019
Q3 | $37K | Sell |
10,937
-2,559
| -19% | -$8.66K | ﹤0.01% | 3749 |
|
|
2019
Q2 | $67K | Sell |
13,496
-16,874
| -56% | -$83.8K | ﹤0.01% | 3750 |
|
|
2019
Q1 | $189K | Sell |
30,370
-8,564
| -22% | -$53.3K | ﹤0.01% | 3056 |
|
|
2018
Q4 | $131K | Sell |
38,934
-25,100
| -39% | -$84.5K | ﹤0.01% | 2876 |
|
|
2018
Q3 | $415K | Buy |
64,034
+13,546
| +27% | +$87.8K | ﹤0.01% | 2732 |
|
|
2018
Q2 | $387K | Sell |
50,488
-23,295
| -32% | -$179K | ﹤0.01% | 2417 |
|
|
2018
Q1 | $1.65M | Buy |
73,783
+68,888
| +1,407% | +$1.54M | ﹤0.01% | 1486 |
|
|
2017
Q4 | $62K | Buy |
4,895
+197
| +4% | +$2.5K | ﹤0.01% | 3259 |
|
|
2017
Q3 | $74K | Buy |
4,698
+2,093
| +80% | +$33K | ﹤0.01% | 2820 |
|
|
2017
Q2 | $36K | Buy |
2,605
+1,205
| +86% | +$16.7K | ﹤0.01% | 3111 |
|
|
2017
Q1 | $31K | Buy |
+1,400
| New | +$31K | ﹤0.01% | 3252 |
|